Navigation Links
KnightStar® 330 Bi-Level® Ventilator

ProductsKnightStar® 330 Bi-Level® Ventilator
Company Puritan Bennett
Item KnightStar® 330 Bi-Level® Ventilator
Features 
  • Low 30 dBA sound output
  • Optional battery mode
  • Backup rate in A/C mode
  • Three selectable modes of ventilation
  • Internal alarms
  • Leak compensation
  • One-year warranty
  • Compatible with complete family of Puritan Bennett® CPAP interfaces, including the Breeze SleepGear CPAP™ Interface System
Description The KnightStar® 330 Ventilator is a blower-based, bi-level positive pressure ventilator system designed to treat spontaneously breathing patients weighing 30 kg or more. The KnightStar 330 can be used to treat respiratory insufficiency and/or obstructive sleep apnea in the home, hospital or other institutional setting. The KnightStar 330 Ventilator includes a 3-30 cm H2O pressure range, an LCD display, pressure ramp and delay settings, patient lockout mode, automatic altitude/leak compensation, built-in audible/visual alarms, adjustable pressure rise time, and inspiratory/expiratory breath trigger sensitivities.
Info Puritan Bennett
Customer Service: (800) 663-3336
Web site: http://www.sandmansleep.com/

Related medicine products :

1. GoodKnight® 425 Bi-Level® Device
2. AV80 Ventilator
3. Ventilator Filter with Flexible Coupler
4. Ventilator Filter with Flexible Coupler and Humidifier Tube
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
... invasive, highly effective surgical alternative for the ... is positioned close to the high pressure ... TVT provides tension-free support of the urethra ... approximately 20 to 30 minutes, with minimal ...
... to treatment is accurate diagnosis of the ... quick, patient-friendly tool designed to aid in ... minimizing patient discomfort. Designed for in-office use, ... type of urethral pressure measurement for stress ...
...
Medicine Products:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: